Advancing Treatment for Immunological Diseases with Real-World Evidence and Data Analytics

August 16th, 2022|Categories: Featured, Industry News|Tags: , , |

Immune-mediated inflammatory diseases (IMIDs) are often difficult and expensive to treat, but new advances are being made with real-world evidence (RWE) and artificial intelligence (AI) by Jannen’s Immunology and R&D Data Science teams. Pulling real-world data (RWD) from a variety of sources, researchers can create phenotypic profiles based on real patients. In addition, RWE and data science allow for more efficient clinical trial design.

Go to Top